Relation of elevated serum adenosine deaminase levels to glycated hemoglobin and serum uric acid in type 2 diabetes mellitus
Abstract
Background: Adenosine deaminase (ADA) is suggested to be an important enzyme for modulating the bioactivity of insulin, but its clinical significance in Type 2 diabetes mellitus is not yet established. The present study was undertaken to evaluate serum ADA activity and serum uric acid levels in patients of Type 2 DM. It is widely reported that immunological imbalance is one of the key factors associated with the metabolic disturbances in type 2 diabetes mellitus.
Aims: The present study aimed to evaluate the serum Adenosine Deaminase level and to correlate ADA levels with Blood Glucose and HbA1c levels in Type-2 Diabetes Mellitus patients.
Material and Method: It is a case control study. The subjects included in this study were divided into 3 groups. Group I consisted of 50 normal healthy individuals who served as controls with no history of DM. Group II consisted of 50 patients of Type 2 Diabetes Mellitus both males & females in the age group of 40-65 years on oral hypoglycemic drugs with HbA1c <7%. Group III consisted of 50 patients of Type 2 Diabetes Mellitus both males & females in the age group of 40-65 years on oral hypoglycemic drugs with HbA1c >7 %. Serum levels of fasting blood sugar, HbA1c, ADA and uric acid were estimated in all the subjects under study.
Results: All the three parameters, FBS, HbA1c, ADA and serum uric acid levels were found to be increased in the patients of Type 2 DM as compared to controls. The mean serum uric acid levels showed a bell shaped relation with glycemic control.
Conclusion: From the present study, it is concluded that there is an increase in serum ADA levels with increase in HbA1c levels. It was found that the serum uric acid levels increased with increasing levels of HbA1c <7% and then decreased with further increasing levels of HbA1c >7% (a bell-shaped relation).
Downloads
References
Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res. 2007 Mar; 125(3):217-30.http://www.ijmr.org.in/temp/IndianJMedRes1253217-3637285_100612.pdf.
American Diabetes Association. ‘Diagnosis and classification of diabetes mellitus’, Diabetes Care 2014; 37:S81-S90.doi: https://doi.org/10.2337/dc14-S081.
Vanitha Gowda M. N. & Vasudha K. C. & Reshma S. & Sujatha K. J.. Serum Adenosine deaminase activity in type 2 Diabetes Mellitus patients. Int J Diabetes Dev Ctries 2012; 32(3): 176–181.doi: https://doi.org/10.1007/s13410-012-0087-x.
Vineet Kumar Khemka, Debajit Bagchi, Arindam Ghosh, Oishimaya Sen, Aritri Bir, Sasanka Chakrabarti, and Anindita Banerjee. Raised Serum Adenosine Deaminase Level in Nonobese Type 2 Diabetes Mellitus. The Scientific World Journal Volume 2013: 1-5.
Hoshino T, Yamada K, Masuoka K, Tsuboi I, Itoh K, Nonaka K, Oizumi K. Elevated adenosine deaminase activity in the serum of patients with diabetes mellitus. Diabetes Res Clin Pract. 1994 Sep; 25(2):97-102.doi: https://doi.org/10.1016/0168-8227(94)90034-5.
Sullivan JL, Osborne WR, Wedgewood RJ. Adenosine deaminase activity in lymphocytes. Br J Haematol. 1977 Sep;37(1):157-8.
Prakash MS, Chennaiah S, Murthy YSR, et al. Altered adenosine deaminase activity in Type 2 diabetes mellitus. JIACM 2006; 7(2): 114- 117.http://medind.nic.in/jac/t06/i2/jact06i2p114.pdf.
Hoshino T, Yamada K, Masuoka K, Tsuboi I, Itoh K, Nonaka K, Oizumi K. Elevated adenosine deaminase activity in the serum of patients with diabetes mellitus. Diabetes Res Clin Pract. 1994 Sep;25(2):97-102.
Angielski S, Jakubowski Z, Pawelczyk T, Piec G, Redlak M. Renal handling and metabolism of adenosine in diabetic rats. Contrib Nephrol. 1989;73:52-7; discussion 57-8.doi: https://doi.org/10.1159/000417379.
Lee JG, Kang DG, Yu JR, Kim Y, Kim J, Koh G, Lee D. Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity. Diabetes Metab J. 2011 Apr;35(2):149-58. doi: https://doi.org/10.4093/dmj.2011.35.2.149. Epub 2011 Apr 30.
Delacour H, Sauvanet C, Ceppa F, Burnat P. Analytical performances of the Diazyme ADA assay on the Cobas® 6000 system. Clin Biochem. 2010 Dec;43(18):1468-71. doi: https://doi.org/10.1016/j.clinbiochem.2010.09.005. Epub 2010 Sep 17.
Amandeep Kaur, SahibaKukreja, Naresh Malhotra, Neha. Serum Adenosine Deaminase Activity and Its Correlation with Glycated Haemoglobin Levels in Patients of Type 2 Diabetes Mellitus. Journal of Clinical and Diagnostic Research 2012 April; Vol-6(2): 252-256.http://jcdr.in/articles/PDF/2030/24-%203926.A.pdf.
Kurtul N, Pence S, Akarsu E, Kocoglu H, Aksoy Y, Aksoy H. Adenosine deaminase activity in the serum of type 2 diabetic patients. Acta Medica (Hradec Kralove). 2004;47(1):33-5.doi: https://doi.org/10.14712/18059694.2018.63.
Singh PP, Mahadi F, Roy A and Sharma P. Reactive oxygen species, reactive nitrogen species and antioxidants in etiopathogenesis of diabetes mellitus type -2. Indian Journal of Clinical Biochemistry 2009; 24(4): 324- 342.doi: https://dx.doi.org/10.1007%2Fs12291-009-0062-6.
Ahmed N. Advanced glycation end products- role in pathology of diabetic complications. Diabetes Res Clin Pract. 2005 Jan;67(1):3-21.doi: https://doi.org/10.1016/j.diabres.2004.09.004.
Goldsby RA, Kindt TJ, Osborne BA. Cytokines. Kuby immunology. 4th ed. New York: W.H. Freeman and Company; 2000. p. 320.
Hovi T, Smyth JF, Allison AC, Williams SC. Role of adenosine deaminase in lymphocyte proliferation. Clin Exp Immunol. 1976 Mar;23(3):395-403.
Priti Singh, Salman Khan, Mittal Rabindra Kumar. Adenosine deaminase activity and its relation with glycated hemoglobin and uric acid in type 2 diabetic patients. Iranian Journal of Diabetes and Obesity 2013; (5) number 1. http://ijdo.ssu.ac.ir/article-1-119-en.html.
Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T, Matsuo H, Kikuchi Y, Oda T, Ichida K, Hosoya T, Shimokata K, Niwa T, Kanai Y, Endou H. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature. 2002 May 23; 417(6887):447-52. Epub 2002 Apr 14.doi: https://doi.org/10.1038/nature742.
Ramani Nisha Subash Chandra, Krishna Murthy N, Raghavendra Prasad BN et al. Role of Adenosine Deaminase to Predict Glycemic Status in Type 2 Diabetes Mellitus. Jclin Biomed Sci 2012; 2:123- 132. http://www.jcbsonline.ac.in/Articles/jcbs%20-%202%20(3)_23-33.pdf.
OAI - Open Archives Initiative
